Summit Place Financial Advisors LLC Has $293,000 Stake in Universal Health Services, Inc. (NYSE:UHS)

Summit Place Financial Advisors LLC reduced its holdings in Universal Health Services, Inc. (NYSE:UHSFree Report) by 13.5% during the 3rd quarter, HoldingsChannel reports. The firm owned 1,279 shares of the health services provider’s stock after selling 200 shares during the quarter. Summit Place Financial Advisors LLC’s holdings in Universal Health Services were worth $293,000 as of its most recent filing with the SEC.

Other institutional investors have also made changes to their positions in the company. Financial Management Professionals Inc. acquired a new stake in Universal Health Services in the 3rd quarter valued at approximately $32,000. Blue Trust Inc. raised its stake in Universal Health Services by 1,284.6% during the 2nd quarter. Blue Trust Inc. now owns 180 shares of the health services provider’s stock valued at $33,000 after purchasing an additional 167 shares during the last quarter. Innealta Capital LLC bought a new stake in Universal Health Services in the 2nd quarter valued at $35,000. Headlands Technologies LLC acquired a new stake in Universal Health Services in the 1st quarter worth $36,000. Finally, Denali Advisors LLC bought a new position in shares of Universal Health Services during the 1st quarter worth about $37,000. 86.05% of the stock is currently owned by institutional investors.

Insider Buying and Selling at Universal Health Services

In related news, Director Warren J. Nimetz sold 3,444 shares of the firm’s stock in a transaction dated Monday, August 12th. The stock was sold at an average price of $217.64, for a total value of $749,552.16. Following the transaction, the director now owns 3,971 shares in the company, valued at $864,248.44. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. In other Universal Health Services news, Director Warren J. Nimetz sold 3,444 shares of the firm’s stock in a transaction that occurred on Monday, August 12th. The shares were sold at an average price of $217.64, for a total value of $749,552.16. Following the transaction, the director now directly owns 3,971 shares of the company’s stock, valued at approximately $864,248.44. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Nina Chen-Langenmayr sold 850 shares of the stock in a transaction on Wednesday, August 7th. The shares were sold at an average price of $212.11, for a total value of $180,293.50. Following the completion of the transaction, the director now directly owns 1,985 shares in the company, valued at approximately $421,038.35. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Corporate insiders own 16.10% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities research analysts recently weighed in on UHS shares. Wells Fargo & Company increased their target price on shares of Universal Health Services from $255.00 to $275.00 and gave the company an “overweight” rating in a research note on Tuesday, October 22nd. UBS Group boosted their price objective on Universal Health Services from $247.00 to $267.00 and gave the company a “buy” rating in a research report on Wednesday, August 14th. StockNews.com raised Universal Health Services from a “buy” rating to a “strong-buy” rating in a research report on Saturday, October 19th. The Goldman Sachs Group increased their price objective on shares of Universal Health Services from $200.00 to $229.00 and gave the company a “buy” rating in a research note on Tuesday, July 30th. Finally, Stephens reiterated an “equal weight” rating and set a $200.00 target price on shares of Universal Health Services in a research report on Thursday, July 25th. Five analysts have rated the stock with a hold rating, nine have assigned a buy rating and two have assigned a strong buy rating to the company. According to MarketBeat.com, Universal Health Services presently has a consensus rating of “Moderate Buy” and a consensus target price of $232.46.

Read Our Latest Analysis on UHS

Universal Health Services Price Performance

Shares of UHS stock opened at $204.00 on Monday. The stock’s fifty day moving average is $229.55 and its 200-day moving average is $201.23. The company has a debt-to-equity ratio of 0.69, a quick ratio of 1.28 and a current ratio of 1.39. Universal Health Services, Inc. has a 52 week low of $121.55 and a 52 week high of $243.25. The stock has a market capitalization of $13.61 billion, a PE ratio of 13.48, a PEG ratio of 0.67 and a beta of 1.27.

Universal Health Services (NYSE:UHSGet Free Report) last announced its earnings results on Thursday, October 24th. The health services provider reported $3.71 earnings per share for the quarter, missing analysts’ consensus estimates of $3.75 by ($0.04). Universal Health Services had a return on equity of 15.75% and a net margin of 6.66%. The company had revenue of $3.96 billion during the quarter, compared to the consensus estimate of $3.90 billion. During the same period in the prior year, the firm posted $2.55 earnings per share. The company’s revenue was up 11.3% on a year-over-year basis. Equities research analysts expect that Universal Health Services, Inc. will post 15.9 EPS for the current fiscal year.

Universal Health Services declared that its Board of Directors has authorized a share repurchase program on Wednesday, July 24th that permits the company to buyback $1.00 billion in outstanding shares. This buyback authorization permits the health services provider to repurchase up to 8% of its shares through open market purchases. Shares buyback programs are usually an indication that the company’s leadership believes its stock is undervalued.

Universal Health Services Profile

(Free Report)

Universal Health Services, Inc, through its subsidiaries, owns and operates acute care hospitals, and outpatient and behavioral health care facilities. It operates through Acute Care Hospital Services and Behavioral Health Care Services segments. The company's hospitals offer general and specialty surgery, internal medicine, obstetrics, emergency room care, radiology, oncology, diagnostic and coronary care, pediatric services, pharmacy services, and/or behavioral health services.

Further Reading

Want to see what other hedge funds are holding UHS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Universal Health Services, Inc. (NYSE:UHSFree Report).

Institutional Ownership by Quarter for Universal Health Services (NYSE:UHS)

Receive News & Ratings for Universal Health Services Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Universal Health Services and related companies with MarketBeat.com's FREE daily email newsletter.